Clinical research in pharmaceutical development:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
Dekker
1996
|
Schriftenreihe: | Drugs and the pharmaceutical sciences
75 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XIV, 360 S. graph. Darst. |
ISBN: | 0824797450 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV011008029 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 961018s1996 d||| |||| 00||| eng d | ||
020 | |a 0824797450 |9 0-8247-9745-0 | ||
035 | |a (OCoLC)34926882 | ||
035 | |a (DE-599)BVBBV011008029 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-12 | ||
050 | 0 | |a RM301.27 | |
082 | 0 | |a 615/.1901 |2 20 | |
084 | |a XI 1700 |0 (DE-625)152977:12905 |2 rvk | ||
245 | 1 | 0 | |a Clinical research in pharmaceutical development |c ed. by Barry Bleidt ... |
264 | 1 | |a New York [u.a.] |b Dekker |c 1996 | |
300 | |a XIV, 360 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Drugs and the pharmaceutical sciences |v 75 | |
650 | 4 | |a Médicaments - Essais cliniques | |
650 | 4 | |a Pharmacologie clinique | |
650 | 4 | |a Chemistry, Pharmaceutical |z United States | |
650 | 4 | |a Clinical Trials as Topic |z United States | |
650 | 4 | |a Clinical pharmacology | |
650 | 4 | |a Drug Industry |z United States | |
650 | 4 | |a Drugs |x Testing | |
650 | 4 | |a Socioeconomic Factors |z United States | |
650 | 0 | 7 | |a Wirtschaftlichkeit |0 (DE-588)4066424-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Ethik |0 (DE-588)4015602-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 1 | 1 | |a Ethik |0 (DE-588)4015602-3 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 2 | 1 | |a Wirtschaftlichkeit |0 (DE-588)4066424-7 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Bleidt, Barry |e Sonstige |4 oth | |
830 | 0 | |a Drugs and the pharmaceutical sciences |v 75 |w (DE-604)BV000002008 |9 75 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007370511&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-007370511 |
Datensatz im Suchindex
_version_ | 1804125499600928768 |
---|---|
adam_text | CLINICAL RESEARCH IN PHARMACEUTICAL DEVELOPMENT EDITED BY BARRY BLEIDT,
HEALTH RESOURCES CONSULTING SOUTH CHARLESTON, WEST VIRGINIA MICHAEL
MONTAGNE MASSACHUSETTS COLLEGE OF PHARMACY AND ALLIED HEALTH SCIENCES
BOSTON, MASSACHUSETTS MARCEL DEKKER, INC. NEW YORK* BASEL * HONG KONG
CONTENTS PREFACE V CONTRIBUTORS XIII PART I INTRODUCTION 1. CLINICAL
RESEARCH IN PHARMACEUTICAL DEVELOPMENT: AN OVERVIEW 1 BARRY BLEIDT AND
MICHAEL MONTAGNE 2. PHARMAGENY: THE NEW PRODUCT DEVELOPMENT PROCESS 19
BARRY BLEIDT PART II KEYNOTE SECTION 3. PLANNED RESEARCH AND CHANCE
DISCOVERY IN PHARMACEUTICAL DEVELOPMENT 27 ALBERT HOFMANN CONTENTS PART
III THE DRUG DEVELOPMENT PROCESS 4. A BRIEF HISTORY OF CLINICAL RESEARCH
IN PHARMACEUTICAL DEVELOPMENT 45 DONALD D. VOGT AND MICHAEL MONTAGNE 5.
THE ROLE OF CLINICAL RESEARCH IN THE DRUG DEVELOPMENT PROCESS 61 MICHAEL
MONTAGNE 6. THE FDA AND THE REGULATORY OVERSIGHT OF THE CLINICAL
RESEARCH PROCESS IN DRUG DEVELOPMENT 79 LOREN MILLER AND LLOYD G.
MILLSTEIN PART IV CLINICAL DRUG RESEARCH 7. PHARMACOKINETICS:
INTERACTIONS OF NEW DRUGS AND THE HUMAN BODY 109 GAMAL HUSSEIN AND BARRY
BLEIDT 8. PLANNING, COORDINATING, AND MONITORING CLINICAL TRIALS 125
BARRY BLEIDT 9. THE PROTOCOL, CASE REPORT FORMS, AND PATIENT CONSENT 151
BARRY BLEIDT 10. PATIENT OUTCOMES AND DRUG USEFULNESS 195 BARRY BLEIDT
11. PHARMACOECONOMICS AND QUALITY OF LIFE: EVALUATING THE ECONOMIC AND
SOCIAL IMPACT OF PHARMACEUTICALS 213 WILLIAM F. MCGHAN PART V SOCIAL AND
LEGAL ASPECTS 12. PHARMACEUTICAL MARKETING 233 MICKEY C. SMITH AND LISA
RUBY BASARA CONTENTS XI 13. ETHICS IN CLINICAL DRUG RESEARCH 259 ROBERT
L. MCCARTHY 14. LEGAL ASPECTS OF PRESCRIPTION DRUG DEVELOPMENT IN THE
UNITED STATES 281 HORACE D. NALLE 15. SOCIAL ASPECTS OF PHARMACEUTICAL
DEVELOPMENT 317 MICHAEL MONTAGNE NOMENCLATURE 337 GLOSSARY 341 INDEX 351
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV011008029 |
callnumber-first | R - Medicine |
callnumber-label | RM301 |
callnumber-raw | RM301.27 |
callnumber-search | RM301.27 |
callnumber-sort | RM 3301.27 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 1700 |
ctrlnum | (OCoLC)34926882 (DE-599)BVBBV011008029 |
dewey-full | 615/.1901 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.1901 |
dewey-search | 615/.1901 |
dewey-sort | 3615 41901 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02297nam a2200589 cb4500</leader><controlfield tag="001">BV011008029</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">961018s1996 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824797450</subfield><subfield code="9">0-8247-9745-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34926882</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011008029</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.27</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1901</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1700</subfield><subfield code="0">(DE-625)152977:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical research in pharmaceutical development</subfield><subfield code="c">ed. by Barry Bleidt ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 360 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">75</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Essais cliniques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacologie clinique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Socioeconomic Factors</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftlichkeit</subfield><subfield code="0">(DE-588)4066424-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Wirtschaftlichkeit</subfield><subfield code="0">(DE-588)4066424-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bleidt, Barry</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">75</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">75</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007370511&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007370511</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV011008029 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:02:32Z |
institution | BVB |
isbn | 0824797450 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007370511 |
oclc_num | 34926882 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-12 |
owner_facet | DE-355 DE-BY-UBR DE-12 |
physical | XIV, 360 S. graph. Darst. |
publishDate | 1996 |
publishDateSearch | 1996 |
publishDateSort | 1996 |
publisher | Dekker |
record_format | marc |
series | Drugs and the pharmaceutical sciences |
series2 | Drugs and the pharmaceutical sciences |
spelling | Clinical research in pharmaceutical development ed. by Barry Bleidt ... New York [u.a.] Dekker 1996 XIV, 360 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 75 Médicaments - Essais cliniques Pharmacologie clinique Chemistry, Pharmaceutical United States Clinical Trials as Topic United States Clinical pharmacology Drug Industry United States Drugs Testing Socioeconomic Factors United States Wirtschaftlichkeit (DE-588)4066424-7 gnd rswk-swf Ethik (DE-588)4015602-3 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf USA (DE-588)4143413-4 Aufsatzsammlung gnd-content Arzneimittelprüfung (DE-588)4128030-1 s DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s Ethik (DE-588)4015602-3 s Wirtschaftlichkeit (DE-588)4066424-7 s Bleidt, Barry Sonstige oth Drugs and the pharmaceutical sciences 75 (DE-604)BV000002008 75 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007370511&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Clinical research in pharmaceutical development Drugs and the pharmaceutical sciences Médicaments - Essais cliniques Pharmacologie clinique Chemistry, Pharmaceutical United States Clinical Trials as Topic United States Clinical pharmacology Drug Industry United States Drugs Testing Socioeconomic Factors United States Wirtschaftlichkeit (DE-588)4066424-7 gnd Ethik (DE-588)4015602-3 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
subject_GND | (DE-588)4066424-7 (DE-588)4015602-3 (DE-588)4143176-5 (DE-588)4128030-1 (DE-588)4143413-4 |
title | Clinical research in pharmaceutical development |
title_auth | Clinical research in pharmaceutical development |
title_exact_search | Clinical research in pharmaceutical development |
title_full | Clinical research in pharmaceutical development ed. by Barry Bleidt ... |
title_fullStr | Clinical research in pharmaceutical development ed. by Barry Bleidt ... |
title_full_unstemmed | Clinical research in pharmaceutical development ed. by Barry Bleidt ... |
title_short | Clinical research in pharmaceutical development |
title_sort | clinical research in pharmaceutical development |
topic | Médicaments - Essais cliniques Pharmacologie clinique Chemistry, Pharmaceutical United States Clinical Trials as Topic United States Clinical pharmacology Drug Industry United States Drugs Testing Socioeconomic Factors United States Wirtschaftlichkeit (DE-588)4066424-7 gnd Ethik (DE-588)4015602-3 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
topic_facet | Médicaments - Essais cliniques Pharmacologie clinique Chemistry, Pharmaceutical United States Clinical Trials as Topic United States Clinical pharmacology Drug Industry United States Drugs Testing Socioeconomic Factors United States Wirtschaftlichkeit Ethik Arzneimittelentwicklung Arzneimittelprüfung USA Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007370511&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000002008 |
work_keys_str_mv | AT bleidtbarry clinicalresearchinpharmaceuticaldevelopment |